Published in Curr Opin Lipidol on June 01, 1999
Population genomics of human gene expression. Nat Genet (2007) 24.49
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest (2008) 3.36
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res (2000) 2.53
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res (2008) 2.28
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.24
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A (2005) 2.08
Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A (2005) 1.91
Investigating diversity in human plasma proteins. Proc Natl Acad Sci U S A (2005) 1.88
High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem (2010) 1.69
Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res (2010) 1.63
Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc Natl Acad Sci U S A (2001) 1.51
Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology (2009) 1.48
Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet (2002) 1.27
Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol (2009) 1.23
Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet (2002) 1.22
Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study. Eur J Epidemiol (2007) 1.20
Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. Biochemistry (2008) 1.06
Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis (2014) 1.05
Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles. Mol Ther (2012) 1.04
An optimized negative-staining protocol of electron microscopy for apoE4 POPC lipoprotein. J Lipid Res (2009) 1.00
Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol Neurodegener (2009) 0.99
Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol (2010) 0.98
Polymorphism in maternal LRP8 gene is associated with fetal growth. Am J Hum Genet (2006) 0.96
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochim Biophys Acta (2009) 0.96
Genetic factors are important determinants of impaired growth after infant cardiac surgery. J Thorac Cardiovasc Surg (2010) 0.95
An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen (2006) 0.94
Epigenetic signature and enhancer activity of the human APOE gene. Hum Mol Genet (2013) 0.93
AR, apoE, and cognitive function. Horm Behav (2008) 0.92
Apolipoprotein E genotype frequency patterns in aged Danes as revealed by logistic regression models. Eur J Epidemiol (2004) 0.90
Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy. J Mol Biol (2008) 0.90
Lipoprotein metabolism in nonalcoholic fatty liver disease. J Biomed Res (2012) 0.90
Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease. J Neurol Neurosurg Psychiatry (2004) 0.89
Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor. Anal Biochem (2007) 0.89
Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases. PLoS One (2011) 0.89
Impairments in spatial memory retention of GFAP-apoE4 female mice. Behav Brain Res (2006) 0.88
Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain. Biochem J (2005) 0.87
Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3. Arch Biochem Biophys (2012) 0.85
Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease. Neuroimage (2010) 0.85
Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele. J Neuroinflammation (2013) 0.84
Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease. J Am Heart Assoc (2013) 0.83
Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat (2015) 0.83
Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr (2014) 0.82
Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities. J Appl Physiol (1985) (2011) 0.81
Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects. J Lipid Res (2010) 0.81
Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology (2016) 0.81
Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener (2016) 0.80
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant (2010) 0.80
The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. Biomed Res Int (2013) 0.79
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome. J Lipid Res (2012) 0.79
Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2. PLoS One (2015) 0.79
Role of the APOE ε2/ε3/ε4 polymorphism in the development of primary open-angle glaucoma: evidence from a comprehensive meta-analysis. PLoS One (2013) 0.78
APOE genotyping: comparison of three methods. Clin Exp Med (2008) 0.78
Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease. J Health Care Poor Underserved (2013) 0.78
APOE ε4 genotype predicts memory for everyday activities. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2015) 0.78
Localization of genes for V+LDL plasma cholesterol levels on two diets in the opossum Monodelphis domestica. J Lipid Res (2010) 0.77
A functional mutation at position -155 in porcine APOE promoter affects gene expression. BMC Genet (2011) 0.77
Synthetic high-density lipoprotein-like nanoparticles for cancer therapy. Expert Rev Anticancer Ther (2014) 0.76
Association of apolipoprotein E-219T>G promoter polymorphism with primary open angle glaucoma in Turkish population. Int J Ophthalmol (2014) 0.76
Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children. Lipids Health Dis (2016) 0.75
Evolutionary analysis of apolipoprotein E by Maximum Likelihood and complex network methods. Genet Mol Biol (2016) 0.75
Emerging preclinical pharmacological targets for Parkinson's disease. Oncotarget (2016) 0.75
ApoE polymorphisms in narcolepsy. BMC Med Genet (2001) 0.75
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 20.59
Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci U S A (2000) 7.67
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science (1989) 5.60
Indium phosphide nanowires as building blocks for nanoscale electronic and optoelectronic devices. Nature (2001) 5.09
A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science (1999) 4.75
In vivo evidence of structural brain asymmetry in musicians. Science (1995) 4.71
Electrostatic interactions of S4 voltage sensor in Shaker K+ channel. Neuron (1995) 4.49
Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med (2001) 4.27
Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A (1995) 4.00
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int (2016) 3.30
Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials. Int J Clin Pract (2013) 3.16
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med (1998) 3.15
Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng (2000) 2.73
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res (2000) 2.71
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis (1996) 2.70
Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A (2001) 2.65
Changes in Friend murine erythroleukaemia cell membranes during induced differentiation determined by electrorotation. Biochim Biophys Acta (1994) 2.65
Pathway leading to correctly folded beta-tubulin. Cell (1996) 2.55
PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48
HIV-1 subtype and second-receptor use. Nature (1996) 2.46
Case study of the effects of atmospheric aerosols and regional haze on agriculture: an opportunity to enhance crop yields in China through emission controls? Proc Natl Acad Sci U S A (1999) 2.44
Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med (1996) 2.42
Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene (2010) 2.42
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature (1990) 2.39
A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol (1997) 2.16
Cell separation by dielectrophoretic field-flow-fractionation. Anal Chem (2000) 2.13
Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem (2001) 2.06
A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol (2001) 2.04
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res (1998) 2.02
Solution structure of the cellular factor BAF responsible for protecting retroviral DNA from autointegration. Nat Struct Biol (1998) 2.00
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene (2010) 1.91
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res (1999) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Increased corpus callosum size in musicians. Neuropsychologia (1995) 1.85
Cell separation on microfabricated electrodes using dielectrophoretic/gravitational field-flow fractionation. Anal Chem (1999) 1.84
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol (1999) 1.84
Dielectric properties of human leukocyte subpopulations determined by electrorotation as a cell separation criterion. Biophys J (1999) 1.82
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol (1998) 1.80
Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders. Mol Psychiatry (2004) 1.79
Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci U S A (1998) 1.75
Differential analysis of human leukocytes by dielectrophoretic field-flow-fractionation. Biophys J (2000) 1.70
Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene (2012) 1.69
effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther (2006) 1.69
Methods for estimation of subsample time delays of digitized echo signals. Ultrason Imaging (1995) 1.69
Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.67
SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.62
An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR (1998) 1.61
Sex but no hand difference in the isthmus of the corpus callosum. Neurology (1992) 1.60
Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res (1997) 1.60
Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol (1991) 1.58
Effects of mutations in Pr160gag-pol upon tRNA(Lys3) and Pr160gag-plo incorporation into HIV-1. J Mol Biol (1997) 1.58
Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem (2000) 1.57
p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene (1997) 1.57
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. J Infect Dis (2000) 1.55
MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene (2012) 1.55
Vascular lesions in Chinese patients with transient ischemic attacks. Neurology (1997) 1.54
A brief dementia screener suitable for use by non-specialists in resource poor settings--the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia. Int J Geriatr Psychiatry (2010) 1.53
Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem (1998) 1.53
Perspectives on the new kidney disease education benefit: early awareness, race and kidney transplant access in a USRDS study. Am J Transplant (2012) 1.51
Glycosylation of shaker potassium channel protein in insect cell culture and in Xenopus oocytes. Biochemistry (1994) 1.51
Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature (2001) 1.51
The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res (1998) 1.49
The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA. J Virol (1999) 1.49
Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunology (2000) 1.49
Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect (2009) 1.49
Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Natl Acad Sci U S A (1997) 1.48
Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology (1997) 1.48
The relationship between corpus callosum size and forebrain volume. Cereb Cortex (1997) 1.46
Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology (2009) 1.44
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol (1998) 1.44
Pulsed brachytherapy as a substitute for continuous low dose rate: an in vitro study with human carcinoma cells. Int J Radiat Oncol Biol Phys (1997) 1.44
Potential reduced late effects for pulsed brachytherapy compared with conventional LDR. Int J Radiat Oncol Biol Phys (1995) 1.44
Role for p300 in stabilization of p53 in the response to DNA damage. J Biol Chem (1999) 1.43
Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood (1998) 1.42
Degradation of green tea catechins in tea drinks. J Agric Food Chem (2001) 1.42
Identification of a dual-specificity protein phosphatase that inactivates a MAP kinase from Arabidopsis. Plant J (1998) 1.42
Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J (2001) 1.42
Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ (2012) 1.41
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
Deletion of 3'-CBFB gene in association with an inversion (16)(p13q22) and a loss of the Y chromosome in a 2-year-Old child with acute myelogenous leukemia-M4. Cancer Genet Cytogenet (2000) 1.40
Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature (1996) 1.39
Early detection of central airway lung cancer in smokers with silicosis. Int J Tuberc Lung Dis (2011) 1.39
Non-uniform spatial distributions of both the magnitude and phase of AC electric fields determine dielectrophoretic forces. Biochim Biophys Acta (1995) 1.39
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol (1996) 1.39
Microwave life-detection systems for searching human subjects under earthquake rubble or behind barrier. IEEE Trans Biomed Eng (2000) 1.39
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia (2009) 1.38
Transcriptional regulation of the GluR2 gene: neural-specific expression, multiple promoters, and regulatory elements. J Neurosci (1998) 1.38
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology (1993) 1.36